PMC10032213_01
Failed graft after repeat penetrating keratoplasties. The patient complained of a significant decrease in vision, redness, grittiness, and pain.
IMCRJ-16-179-g0001.jpg
PMC10032213_01_IMCRJ-16-179-g0001.jpg
f0001
She constantly experiences corneal rejection symptoms after several years of keratoplasty (Figure 1).
Patient one-week post-trabeculectomy with clear graft.
IMCRJ-16-179-g0002.jpg
PMC10032213_01_IMCRJ-16-179-g0002.jpg
f0002
IOP was well controlled after 22 months without antiglaucoma medications (Figures 2 and 3). In April 2022, she came to our clinic with complaints of irritation, redness, and decreased vision in the right eye.
Thin, avascular bleb and no leak at one-month follow-up post-trabeculectomy with mitomycin C.
IMCRJ-16-179-g0003.jpg
PMC10032213_01_IMCRJ-16-179-g0003.jpg
f0003
IOP was well controlled after 22 months without antiglaucoma medications (Figures 2 and 3). In April 2022, she came to our clinic with complaints of irritation, redness, and decreased vision in the right eye.
Scleral thinning 22-months post-trabeculectomy with mitomycin C.
IMCRJ-16-179-g0004.jpg
PMC10032213_01_IMCRJ-16-179-g0004.jpg
f0004
On examination, we found an incarcerated bleb with a positive Seidel test (Figures 4 and 5), 5 mmHg IOP, and BCVA hand movement.
Bleb leak with positive Seidel test viewed after fluorescein staining.
IMCRJ-16-179-g0005.jpg
PMC10032213_01_IMCRJ-16-179-g0005.jpg
f0005
On examination, we found an incarcerated bleb with a positive Seidel test (Figures 4 and 5), 5 mmHg IOP, and BCVA hand movement.
One-week post bleb revision with scleral patch.
IMCRJ-16-179-g0006.jpg
PMC10032213_01_IMCRJ-16-179-g0006.jpg
f0006
One month after surgery, the IOP was 22 mmHg on maximum topical antiglaucoma medications, wound closure was good, and the corneal graft was clear (Figure 6).
Clear graft six months after Ahmed tube implant positioned in the posterior chamber.
IMCRJ-16-179-g0007.jpg
PMC10032213_01_IMCRJ-16-179-g0007.jpg
f0007
Six months after surgery, the IOP was well controlled (11 mmHg) without antiglaucoma medications, BCVA was 0.2, and the graft remained clear (Figures 7 and 8).
Tube positioned behind the iris with extensive peripheral anterior synechia.
IMCRJ-16-179-g0008.jpg
PMC10032213_01_IMCRJ-16-179-g0008.jpg
f0008
Six months after surgery, the IOP was well controlled (11 mmHg) without antiglaucoma medications, BCVA was 0.2, and the graft remained clear (Figures 7 and 8).